The faces behind the figures.

Since opening our doors in 1992, we’ve partnered with leading pharmaceutical and biotechnology companies, the World Health Organization, and the U.S. Food and Drug Administration, as well as provided pharmacology consulting and pharmacometric analyses for more than 100 drugs. But there’s a lot more to us than protocol design and gap analyses. On top of our vast expertise and relentless attention to detail, we also have very charming personalities. Just ask anyone – or better yet, find out for yourself.

We know you’ve been wondering what it’s like. Find out by taking a behind-the-scenes tour.READ MORE

Tuesday, September 26, 2017

Harness the power of pharmacometrics.

Raise your hand if you wish there was a way to make drug development more efficient. Guess what? There is. It’s called model-based drug development, and it involves using quantitative analysis to better design protocols, determine dosage levels, and figure out other neat stuff that lead to successful regulatory filings. Once you see how incredible (and cost-effective) pharmacometrics can be, you’ll be hooked.